Cell News and Research

RSS

Cochlear avatars provide a platform for deciphering the mechanisms of sensorineural hearing loss

Disabling hearing loss affects one in every ten people and up to 25% of people over 60, according to the World Health Organization, and can have both genetic and environmental causes such as infections and noise exposure.

1 Feb 2023

Two million euro ERC Consolidator Grant awarded for finding new therapies against pancreatic cancer

The "Pancreatic ductal adenocarcinoma" (PDAC) is by far the most common form of cancer of the pancreas. PDAC tumors have an extremely poor prognosis because of several reasons.

31 Jan 2023

New discovery about "killer torpedoes" may be the next breakthrough in cancer treatment

In our body, we have both an innate immune system and an immune system that is developed throughout life. Part of the innate immune system consists of so-called NK cells.

31 Jan 2023

Experts discover mechanism of recruitment for tumor-associated cells in lung adenocarcinoma

A team of experts from the University of Barcelona, the University of Zaragoza and Hospital Clínic de Barcelona found a mechanism of recruitment for tumour-associated cells (cancer-associated fibroblasts or CAFs) which are essential to lung adenocarcinoma, the most frequent type of cancer.

31 Jan 2023

Researchers develop new way to increase the potency of cancer vaccines

A new way to significantly increase the potency of almost any vaccine has been developed by researchers from the International Institute for Nanotechnology (IIN) at Northwestern University.

31 Jan 2023

New technique offers a two-prong approach to attacking cancers

When noninvasive sound waves break apart tumors, they trigger an immune response in mice. By breaking down the cell wall "cloak," the treatment exposes cancer cell markers that had previously been hidden from the body's defenses, researchers at the University of Michigan have shown.

31 Jan 2023

Cancer immunotherapy does not interfere with COVID-19 immunity in vaccinated patients, study shows

Research findings published in Frontiers in Immunology show that cancer immunotherapy does not interfere with COVID-19 immunity in previously vaccinated patients.

31 Jan 2023

Study opens new therapeutic avenues for treatment of rheumatoid arthritis

A research team, led by Professor Sung Ho Park in the Department of Biological Sciences at UNIST announced the results of a study on osteoblasts that damage joint bones in patients with rheumatoid arthritis.

31 Jan 2023

Actin influences cancer metastases in many ways

Metastases occur when cancer cells leave a primary tumor and spread throughout the body. For this, they have to break connections with neighboring cells and migrate to other tissues.

31 Jan 2023

Researchers devise a novel potential IBD treatment strategy that eliminates pathogenic T cells and encourages the proliferation of regulatory T cells

Researchers investigated the CAMCI strategy as an immunotherapeutic option for inflammatory bowel disease.

31 Jan 2023

Ants show the potential to become a fast, efficient, inexpensive, and non-invasive tool for the detection of human tumors

Researchers demonstrated the use of ants as olfactory bio-detectors of human tumors.

31 Jan 2023

The impact of common viral infections on blood-brain barrier function and insulin sensitivity

A new study discusses the impact of several human viruses on blood-brain barrier function and insulin sensitivity.

31 Jan 2023

Cornell research provides new insight into chemotherapy agent's effect on DNA

New Cornell research is providing a fresh view into the ways a common chemotherapy agent, etoposide, stalls and poisons the essential enzymes that allow cancer cells to flourish.

30 Jan 2023

Study finds link between tumor microbiome and immune system in sarcoma patients

In a significant new study, UC Davis Comprehensive Cancer Center researchers have uncovered a link between a patient's microbiome and their immune system that can potentially be used to improve the treatment of soft tissue sarcoma.

30 Jan 2023

Structure and function of the first FDA-approved treatment for Ebola virus discovered

Scientists at La Jolla Institute for Immunology (LJI) have uncovered the structure and function of the first FDA-approved treatment for Zaire ebolavirus (Ebola virus).

30 Jan 2023

New biomaterial allows for treating damaged tissue from the inside out

A new biomaterial that can be injected intravenously, reduces inflammation in tissue and promotes cell and tissue repair.

30 Jan 2023

New discovery about microglia heralds myriad possibilities for treating neurodegenerative diseases

Combating Alzheimer's and other neurodegenerative diseases by inserting healthy new immune cells into the brain has taken a leap toward reality.

30 Jan 2023

UT Southwestern physician-scientist wins NIH award to support heart regeneration research

UT Southwestern physician-scientist Hesham Sadek, M.D., Ph.D., has received the prestigious National Institutes of Health Outstanding Investigator Award to support his ongoing research into mechanisms behind heart regeneration that could lead to treatments for heart failure.

30 Jan 2023

New candidate molecule could become an effective non-hormonal male contraceptive

Despite birth control existing for decades, almost none of the options specifically target sperm cells. Researchers are now developing approaches that target testosterone or otherwise interrupt the sperm's ability to fertilize an egg, yet these may not work for everyone.

30 Jan 2023

Study focuses on plasticity of the synapses between the hypothalamus and hippocampus

The complexity of the human brain is unparalleled. Fortunately, thanks to constant progress in neuroscience over the past decades, we have started to make some sense of the human brain.

30 Jan 2023

Cell News and Research

Cochlear avatars provide a platform for deciphering the mechanisms of sensorineural hearing loss

Two million euro ERC Consolidator Grant awarded for finding new therapies against pancreatic cancer

New discovery about "killer torpedoes" may be the next breakthrough in cancer treatment

Experts discover mechanism of recruitment for tumor-associated cells in lung adenocarcinoma

Researchers develop new way to increase the potency of cancer vaccines

New technique offers a two-prong approach to attacking cancers

Cancer immunotherapy does not interfere with COVID-19 immunity in vaccinated patients, study shows

Study opens new therapeutic avenues for treatment of rheumatoid arthritis

Actin influences cancer metastases in many ways

Researchers devise a novel potential IBD treatment strategy that eliminates pathogenic T cells and encourages the proliferation of regulatory T cells

Ants show the potential to become a fast, efficient, inexpensive, and non-invasive tool for the detection of human tumors

The impact of common viral infections on blood-brain barrier function and insulin sensitivity

Cornell research provides new insight into chemotherapy agent's effect on DNA

Study finds link between tumor microbiome and immune system in sarcoma patients

Structure and function of the first FDA-approved treatment for Ebola virus discovered

New biomaterial allows for treating damaged tissue from the inside out

New discovery about microglia heralds myriad possibilities for treating neurodegenerative diseases

UT Southwestern physician-scientist wins NIH award to support heart regeneration research

New candidate molecule could become an effective non-hormonal male contraceptive

Study focuses on plasticity of the synapses between the hypothalamus and hippocampus

Industry focus eBook - Cell and gene therapy (2nd edition) eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics